CLINUVEL implements strategic reorganisation to refocus on U.S. markets
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce, effective 1 January 2027, concurrent wi…
CLINUVEL upgrades U.S. listing to Nasdaq under ticker 'CUVL'
CLINUVEL PHARMACEUTICALS (CLVLY [https://seekingalpha.com/symbol/CLVLY]) (CLVLF [https://seekingalpha.com/symbol/CLVLF]) announced that its American Depositary Shares (ADS) are expected to commence [https://seekingalpha.com/pr/20587437-cli…
MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the Nasdaq Stock Market (Nasdaq) later today (New…